Join us for a timely policy discussion about the 21st Century Cures initiative with its co-creator Rep. Fred Upton (MI-06).
The call will also feature perspectives from Jeanne Haggerty (BIO) and Elizabeth Pike Sharp (AdvaMed) regarding the initiatives' possible implications for the biopharma and medical device sectors, respectively.
The 21st Century Cures initiative is a bipartisan effort from the House Energy and Commerce Committee (with Rep. Diana DeGetter (D-CO)) to accelerate biomedical innovation by ensuring that U.S. laws and regulations keep pace with the tremendous pace of scientific achievement. 21st Century Cures is exploring the “full arc of [the] process – from the discovery of clues in basic science, to streamlining the drug and device development process, to unleashing the power of digital medicine and social media at the treatment delivery phase.”
Chairman Upton released draft legislation in January and hopes to have a bill passed through the House by Memorial Day.
A complimentary biomedical innovation initiative was also introduced to the Senate by Health, Education, Labor, and Pensions (HELP) Committee Chairman Lamer Alexander (R-TN) and Ranking Member Patty Murray (D-WA).
||This event is exclusively for MichBio members.
General questions or any for Rep. Upton may be submitted in advance via email or phone at email@example.com or 734.527.9150.
Congressman Fred Upton (MI-06) is proud to represent the commonsense values of southwest Michigan. In 2010, Fred was selected by his House colleagues to serve as Chairman of the Committee on Energy and Commerce, which has jurisdiction over matters concerning energy, healthcare, the environment, telecommunications, commerce, manufacturing, and trade, as well as oversight and investigations.
Prior to his election to Congress, Fred worked for President Ronald Reagan in the Office of Management and Budget (OMB). While at OMB, he learned from President Reagan’s example that it does not matter who gets the credit, as long as the job gets done.
Fred has pushed for a greater emphasis on biomedical research to improve the public health. As Energy and Commerce Chairman, one of Fred’s top priorities is to repeal the President’s controversial healthcare law and replace it with commonsense, market-based reforms that benefit patients, doctors, and employers.
[Read Upton’s full bio]
Jeanne Haggerty currently serves as Vice President, Federal Government Relations for the Biotechnology Industry Organization (BIO). (Haggerty will be participating instead of the originally-announced Brent Del Monte.)
Elizabeth Pika Sharp
Elizabeth Pika Sharp is Senior Vice President, Government Affairs, of the Advanced Medical Technology Association (AdvaMed). Elizabeth leads the AdvaMed advocacy efforts related to FDA issues, including the 2012 successful reauthorization of MDUFA.
Prior to joining AdvaMed in 2008, Elizabeth worked on Capitol Hill for Senator Blanche Lincoln (D-AR) and Congresswoman Tammy Baldwin (D-WI), where she handled all health care issues that came before the House Committee on Energy and Commerce Committee.
Originally from Newark, DE, Elizabeth earned a master’s degree in Public Policy from Duke University and a bachelor’s degree from Franklin and Marshall College in Lancaster, PA.
About MichBio Policy Call-Ins
Policy Call-In meetings allow voluntary participation in a live conference call with Stephen Rapundalo, President and CEO, on timely policy topics. This format permits individuals the ability to ask questions or simply listen in.
The sessions will be held on a regular basis, sometimes to coincide with major legislative events such as fly-ins or when circumstances necessitate that MichBio procure input from its members. On occasion the Call-In will feature guest legislators or policymakers speaking directly to the issues and participants can openly interact with them.
Policy Call-Ins are available to MichBio members exclusively. Not a member? Join here.